NCT02822287View on ClinicalTrials.gov

Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough

PHASE3CompletedINTERVENTIONAL

Enrollment

58

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Common Cold

Interventions

DRUG

Acetylcystine

Clear oral solution containing 2% acetylcysteine (g/mL) in a 100 mL amber glass bottle.

Trial Locations (1)

99084

GSK Investigational Site, Erfurt

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT02822287 - Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough | Biotech Hunter | Biotech Hunter